Skip to content
★ Sign in to follow
DP

Donald P. Braun

Board Director
Director
Total declarations
6
Company
1
▲ Purchases (2 ops.)
€31k
▼ Sales (0 ops.)
—

Latest filing published 04 Aug 2026 for Imunon, Inc., €8,531.

Filing timeline

BuySale
Donald P. Braun

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2
Positive at T+90
0%
Median T+90
-10.4%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 28 Jan 2025 · 649 days ago · €26k
    -71.8%
    Entry US$11.74 · Close at T+365 US$3.31
  • Filed 20 May 2021 · 1998 days ago · €4,401
    -86.8%
    Entry US$232.83 · Close at T+365 US$30.78

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Donald P. Braun: trading record in brief

Donald P. Braun (board member) discloses dealings in Imunon, Inc. to SEC (Form 4). The record holds 6 filings, for trades running from 2 February 2016 to 31 July 2026.

No open-market sale appears; the market trades are 2 purchases worth €31k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 4 share grants.

The record was last updated on 4 August 2026 with a share grant (€8,531) in Imunon, Inc. The most recent open-market purchase was published on 28 January 2025, 649 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Donald P. Braun

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations6 total
  • ◆
    DirectorExecutivesImunon, Inc.
    9,826 USD12SEC
    6,180 shares@ US$1.590.13% mcap13.1% of flowCommon StockSEC:0001437749-26-025663:0
  • ◆
    DirectorExecutivesImunon, Inc.
    11,024 USD13SEC
    5,011 shares@ US$2.2015.6% of flowCommon StockSEC:0001437749-26-018548:0
  • ◆
    DirectorExecutivesImunon, Inc.
    18,768 USD16SEC
    2,040 shares@ US$9.2026.7% of flowCommon StockSEC:0001437749-25-025098:0
  • ▲
    DirectorExecutivesImunon, Inc.
    29,480 USD30SEC
    25,000 shares@ US$1.179243.6% of flowCommon StockSEC:0001437749-25-002027:0
    Canonical exit: 18 Nov 2024 (T+90)
  • ▲
    DirectorExecutivesImunon, Inc.
    5,350 USD19SEC
    5,000 shares@ US$1.07100.0% of flowCelsion Corporation Common StockSEC:0001437749-21-012889:0
    Canonical exit: 15 Aug 2021 (T+90)
  • ◆
    DirectorExecutivesImunon, Inc.
    0SEC
    5,000 sharesCelsion Corporation Common StockSEC:0001437749-16-024783:0

6 of 6 declarations